Journal Of Clinical Oncology (jco) Podcast
HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:22
- More information
Informações:
Synopsis
Dr. Shannon Westin and her guest, Dr. Helena Yu discuss the paper "HERTHENA-Lung01, a Phase 2 Trial of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI Therapy and Platinum-Based Chemotherapy" published in the JCO during the World Conference on Lung Cancer in Singapore.